The treatment of Age-Related Cognitive Decline & Bladder Infection with vitamins
Age-Related Cognitive Decline and Bladder Infection: Mitamins custom make quality formulas for the treatment of Age-Related Cognitive Decline & Bladder Infection with vitamins. A Age-Related Cognitive Decline & Bladder Infection formula will be made to suit you, using quality brand name ingredients. Mitamins produce custom made vitamin and supplement formulas to suit your individual health needs conveniently in one formula, one bottle and one dosage. For assistance, call toll free: 1-866-585-1390
Your Supplements Facts - Covers the formulas above
Name Your Supplement Bottle - Just how you like it
Your Perfect Supplement - Custom-made just for you
Age-Related Cognitive Decline and Bladder Infection
Serving Size:4-5
Age-Related Cognitive Decline and Bladder Infection Formulas Details
Latest Health Related News:
King Pharmaceuticals And Palatin Technologies Announce End-of-Phase 2 Meeting With FDA For BremelanotidePalatin Technologies, Inc. (Amex: PTN) and King Pharmaceuticals, Inc. (NYSE: KG) announced today that the U.S. Food and Drug Administration (FDA) has scheduled an End-of-Phase 2 meeting to discuss clinical study results with bremelanotide for the treatment of erectile dysfunction (ED). Palatin Technologies submitted a meeting request to FDA in May 2007; FDA has scheduled the meeting for August 2007.
Patient Dosing in Phase 2 Clinical Trial of Puricase for Severe Gout CompletedSavient Pharmaceuticals, Inc (NASDAQ: SVNT), an emerging specialty pharmaceutical company engaged in developing, manufacturing and marketing pharmaceutical products that address unmet medical needs today announced the completion of patient dosing in a Phase 2 clinical trial of Puricase(R), a poly(ethylene glycol) ("PEG") conjugate of recombinant porcine uricase (urate oxidase), for the treatment of severe, refractory gout.
This information concerning the support of Age-Related Cognitive Decline and Bladder Infection treatments provide basic knowledge which should always be discussed with your own health practitioner.